🇺🇸 FDA
Patent

US 7259161

Compositions useful as inhibitors of JAK and other protein kinases

granted A61PA61P1/04A61P1/16

Quick answer

US patent 7259161 (Compositions useful as inhibitors of JAK and other protein kinases) held by Vertex Pharmaceuticals Incorporated expires Mon Aug 16 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Aug 21 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 16 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61P, A61P1/04, A61P1/16, A61P11/02, A61P11/06